|Basis of Allotment|
is only an advertisement for Information purpose. This is not a Prospectus announcement
and does not constitute an invitation or offer to acquire, purchase or subscribe for
securities. Not for publication or distribution, directly or indirectly outside India.)
SHREE RAM PROTEINS LIMITED
Our company was incorporated as Shree Ram Protiens Private Limited under the provision of the companies Act, 1956 vide certificate of incorporation dated August 29, 2008. issued by RoC Gujarat Dadra and Nagar Havelli bearing Corporate Identification Number U01405GJ2008PTC054913. Consequently, it was converted into a public limited company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of our Company held on September 28, 2017 and the name of our Company was changed to Shree Ram Protiens Limited and a fresh certificate of incorporation consequent upon Conversion of Private Company to Public Limited dated October 06,2017 was issued by Registrar of Companies, Ahmedabad. Subsequently the Name our Company was changed from Shree Ram Protiens Limited to Shree Ram Proteins Limited vide fresh certificate of Incorporation Dated November 29,2017 issued by Registrar of Companies Ahmedabad. The Corporate Identification Number of our Company is U101405GJ2008PLC054913 For further details of Incorporation, Change of Name and Registered Office of our company, please refer to chapter titled "General Information' and "Our History and Certain Other Corporate Matters" beginning on page 50 and page 134 of the Prospectus.
Registered Office: Imperial Heights Tower-B, Second
Floor, Office No. B-206,150 Ft Ring Road, Opp Big Bazar Rajkot Gujarat 360005 India
PROMOTERS OF OUR COMPANY: LAVJIBHAI VALJIBHAI SAVALIYA AND LALITKUMAR CHANDHULAL VASOYA
BASIS OF ALLOTMENT
INITIAL PUBLIC OFFER CONSISTING OF FRESH ISSUE OF 64,20,000 EQUITY SHARES OF FACE VALUE OF RS. 10/- EACH FULLY PAID FOR CASH AT A PRICE OF RS. 31/- PER EQUITY SHARE (THE "ISSUE PRICE") (INCLUDING A SHARE PREMIUM OF RS. 21/- PER EQUITY SHARE) AGGREGATING RS. 1990.20 LAKHS (THE "ISSUE"), OF WHICH 3,24,000 EQUITY SHARES OF FACE VALUE OF RS. 10/- EACH FOR CASH AT A PRICE OF RS. 31/- PER EQUITY SHARE, AGGREGATING RS. 100.44 LAKHS WILL BE RESERVED FOR SUBSCRIPTION BY THE MARKET MAKER TO THE ISSUE (THE "MARKET MAKER RESERVATION PORTION"). THE ISSUE LESS MARKET MAKER RESERVATION PORTION I.E. ISSUE OF 60,96,000 EQUITY SHARES OF FACE VALUE OF RS. 10/- EACH FOR CASH AT A PRICE OF RS. 31/- PER EQUITY SHARE, AGGREGATING RS. 1889.76 LAKHS IS HEREINAFTER REFERED TO AS THE "NET ISSUE". THE ISSUE AND THE NET ISSUE WILL CONSTITUTE 29.97% AND 28.46% RESPECTIVELY OF THE FULLY DILUTED POST ISSUE PAID UP EQUITY SHARE CAPITAL OF OUR COMPANY.
Risks to Investors:
I. As on date of the Prospectus, the average cost of acquisition per Equity Share by
our Promoters viz. Lavjibhai Savliya is 9.24, Laitkumar Vasoya is 9.81.
(a) minimum of 50% of the Net Offer to Public shall initially be made available to
Retail Individual Investors.
All Investors have participated in this offer through ASBA process. For details in this regards, specific attention is invited to chapter "Issue Procedure" on page 218 of the Prospectus.
THE FACE VALUE OF EQUITY SHARES IS RS. 10/- EACH.
The Equity Shares of our Company issued through the Prospectus are proposed to be listed on the EMERGE Platform of National Stock Exchange of India Limited ('NSE EMERGE'). In terms of the Chapter XB of the SEBI (ICDR) Regulations, 2009 as amended from time to time. Our Company has received an approval letter dated December 29, 2017 from NSE EMERGE for using its name in the Issue document for listing of our shares on the EMERGE Platform of National Stock Exchange of India Limited. For the purpose of this Issue, EMERGE Platform of the National Stock Exchange of India Limited shall be the Designated Stock Exchange.
The Issue has received 5233 applications for 2,96,84,000 Equity shares (Before Technical Rejections, bids not banked, invalid duplicate bids and invalid multiple bids) including Market Maker Application of 3,24,000 Equity Shares. The issue was subscribed to the extent of 4.6237 times as per the application data (before technical rejection, bids not banked, invalid duplicate bids and invalid multiple bids). After considering the technical rejections cases, the issue was subscribed 4.2654 times. The details of application received (Before Technical Rejection but after bids not banked, invalid duplicate bids and invalid multiple bids)
ALLOCATION: The Basis of Allotment was finalized in consultation with the Designated Stock Exchange - EMERGE Platform of the National Stock Exchange of India Limited on January 31,2018
Allocation to Market Maker (After Technical Rejections and bids not banked): The Basis of Allotment to the Market Maker, at the issue price of Rs. 31/- per Equity Share, was finalized in consultation with National Stock Exchange of India Limited. The category was subscribed by 1.00 times. The total number of shares allotted in this category is 3,24,000 Equity shares in full out of reserved portion of 3,24,000 Equity Shares.
B.AIIocation to Retail Individual Investors (After Technical Rejections and bids not banked): The Basis of Allotment to the Retail Individual Investors, at the issue price of Rs. 31/- per Equity Share, was finalized in consultation with National Stock Exchange of India Limited. The category was subscribed by 4.4356 times. Total number of shares allotted in this category is 44,08,000 Equity Shares. The category wise basis of allotment is as under:
*The Retail Individual Investors category is entitled to more than fifty percent i.e. 72.25% of Net Issue on proportionate basis.
C. Allocation to Other than Retail Individual Investor (After Technical
Rejection and bids not banked): The Basis of Allotmentto other than Retail
Individual Investors, at the issue price of Rs 31/- per Equity Share, was finalized in
consultation with National Stock Exchange of India Limited. The category was subscribed by
The Board of Directors of the Company at its meeting held on February 01, 2018 has taken on record the Basis of Allocation of Equity Shares approved by the Designated Stock Exchange viz. National Stock Exchange of India Limited and authorized corporate action for allotment of shares in dematerialized form to various successful applicants.
The allotment cum refund advise and/or notice will be dispatched to the address of the Applicants as registered with depositories. Further, the instructions to SCSBs shall be issued on February 01, 2018, 2018 for unblocking of funds. The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. In case the same is not received within prescribed time, Investors may contact the registrarto the Issue at the address given below. The Company is taking steps to get the Equity Shares admitted for trading on the EMERGE Platform of the National Stock Exchange of India Limited within six working days from the date of the closure of the Issue. The trading is proposed to commence on or before Monday February 05, 2018 subject to receipt of listing and trading approvalsfrom NSE.
INVESTORS PLEASE NOTE
The details of the allotment made will be hosted on the website of the Registrar to the Issue at www.linkintime.co.in. All future correspondence in this regard may kindly be addressed to the Registrar quoting full name of the First/ Sole applicant, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Registrar given below:
LINK INTIME INDIA PRIVATE LIMITED
THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF SHREE RAM PROTEINS LIMITED.
Note: All capitalized terms used and not defined herein shall have the respective meanings assigned to them in the Prospectus.